BBK Worldwide Harnesses Apple iPad® to Support Speed-To-Market for Investigational Treatments

Public Launch of BBK's Breakthrough Patient Recruitment Solution at Drug Information Association (DIA) Annual Meeting in Washington, D.C.

Jun 09, 2010, 13:02 ET from BBK Worldwide

BOSTON, June 9 /PRNewswire/ -- BBK Worldwide is expanding its three decades of expertise in supporting clinical R&D with the introduction of its Patient Recruitment Franchise Program at the annual meeting of the DIA in Washington, D.C., 13–17 June 2010. BBK's flagship product for its new program is the FRANCHISE e-BINDER(SM): a flexible and intuitive communication platform that uses the Apple iPad® to facilitate the myriad processes necessary to effectively recruit and manage patients for global clinical trials.

This new franchise model not only realizes significant cost-savings in the execution of patient recruitment programs, it also supports quick, efficient enrollment for multiple studies within the same therapeutic category, as well as multiple protocols for a single compound. "Franchise programs create exponential savings through the economies of scale derived from applying strategies and tactics across multiple studies and countries," said Joan F. Bachenheimer, BBK Worldwide founding principal and CEO. "Using the model of the Patient Recruitment Franchise Program, sponsors are able to consolidate planning and recruitment strategies for immediate and long-term cost reductions that far exceed preferred pricing or volume discounts."

The Apple iPad supports franchise-level initiatives by making it possible to instantly distribute, store, and retrieve information and data with the tap of a finger. "BBK's application of this new and accessible technology skillfully supports clinical research professionals as they work to manage the avalanche of information surrounding clinical trial particulars," said Matthew Stumm, BBK Worldwide creative director. Consider the following audience-specific applications of the FRANCHISE e-BINDER, powered by BBK partner company TCN e-Systems:

  • Investigator meetings made simple through the CONFERENCE e-BINDER(SM).
  • Top-level data sourced and easily retrieved for clinical operations via the EXECUTIVE e-BINDER(SM).
  • The STUDY MANAGER e-BINDER(SM) offers investigators and clinical research coordinators one-stop access to critical forms, inclusion/exclusion criteria, patient materials, etc. Easily adapted for any country/language.
  • The UPDATE e-BINDER(SM) for clinical study managers and monitors provides a hand-held portal to site administration resources – including training, study contact listings, sponsor documentation, clinical assessment tools, and more.

BBK Worldwide representatives will be available to discuss the Patient Recruitment Franchise Program and the FRANCHISE e-BINDER during the annual meeting of the DIA. BBK is exhibiting at booth #1317.

About BBK Worldwide

BBK Worldwide is globally renowned for accelerating time to market for new and improved medicines and treatments by using innovative strategies, programs, and technologies to streamline the clinical trial enrollment process. With offices in Boston, London, Los Angeles, and Osaka – as well as strategic alliance partners in every world region where clinical trials are conducted – BBK Worldwide has evolved into the internationally recognized leader in patient recruitment. BBK continues to reshape its industry by combining its visionary perspective with three decades of experience enrolling thousands of clinical studies in more than 70 countries.

SOURCE BBK Worldwide